A topical cream that helps regulate macrophage activity was effective in treating diabetic foot ulcers, a clinical trial reported. In 236 patients with foot ulcers treated for 16 weeks, the proportion ...

Living with diabetes means constantly keeping an eye on things that most people never have to think twice about. Blood sugar levels, skin changes, foot checks, and meal planning become a way of life.

Adding topical esmolol hydrochloride to standard of care (SOC) significantly improved healing of diabetic foot ulcers, a phase III randomized trial from India showed. During a 12-week treatment phase, ...

Mr. J’s medical history included type 2 DM, DFU with osteomyelitis, obesity, hypothyroidism, and hyperlipidemia. Medications included insulin (Humulin 70/30) b.i.d., levothyroxine, pravastatin, ...

Diabetic patients, especially those with very high hyperglycemia, are at an increased risk of developing foot sores or ulcers. 1 The ulcers are often painless, which may be due to neuropathy or nerve ...

June 5, 2003 — Dermagraft is safe and effective for the treatment of chronic diabetic foot ulcers, according to the results of a multicenter, randomized controlled trial published in the June issue of ...

This study is a randomized, prospected, controlled, clinical trial. A total of 30 patients were recruited from the Diabetic Ambulatory of Endocrinology Unit of the University of Bari (Italy) between ...

BALERNA, Switzerland--(BUSINESS WIRE)--Results of a clinical study recently published in the scientific journal “The International journal of Lower Extremity Wound” show Nexodyn® AcidOxidizing ...

A simple stress ball has been shown to significantly reduce anxiety and pain during sharp debridement commonly used in nursing homes to promote wound healing. Previous research found that squeezing a ...

The diabetic foot ulcer that cost Otis Dahmer one of his little toes began with what appeared to be nothing more than dry, flaking skin. Not being “much of a moisturizer guy,” Dahmer said, he didn’t ...

The first patient has been dosed in a Phase III trial assessing ViroMed’s VM202, the first pivotal study of a gene therapy indicated for patients with nonhealing diabetic foot ulcers (NHU) and ...